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Systematic genetic perturbation screening in human cells remains
technically challenging. Typically, large libraries of chemically
synthesized siRNA oligonucleotides are used, each designed to
degrade a specific cellular mRNA via the RNA interference (RNAi)
mechanism. Here, we report on data from three genome-wide
siRNA screens, conducted to uncover host factors required for
infection of human cells by two bacterial and one viral pathogen.
We find that the majority of phenotypic effects of siRNAs are
unrelated to the intended “on-target” mechanism, defined by full
complementarity of the 21-nt siRNA sequence to a target mRNA.
Instead, phenotypes are largely dictated by “off-target” effects
resulting from partial complementarity of siRNAs to multiple
mRNAs via the “seed” region (i.e., nucleotides 2–8), reminiscent
of the way specificity is determined for endogenous microRNAs.
Quantitative analysis enabled the prediction of seeds that strongly
and specifically block infection, independent of the intended on-
target effect. This prediction was confirmed experimentally by
designing oligos that do not have any on-target sequence
match at all, yet can strongly reproduce the predicted pheno-
types. Our results suggest that published RNAi screens have pri-
marily, and unintentionally, screened the sequence space of
microRNA seeds instead of the intended on-target space of pro-
tein-coding genes. This helps to explain why previously pub-
lished RNAi screens have exhibited relatively little overlap. Our
analysis suggests a possible way of identifying “seed reagents” for
controlling phenotypes of interest and establishes a general strat-
egy for extracting valuable untapped information from past and
future RNAi screens.
high-throughput RNAi screening | antimicrobials
High-throughput, genome-wide perturbation screening is apowerful tool for uncovering novel genes and pathways
responsible for phenotypes or functions of interest (1). In
many model organisms, systematic collections of deletion or
knockout strains have been established, enabling well-controlled
and efficient screening experiments. In contrast, when working
with human cells, the technical possibilities for gene perturba-
tions are much more limited. Although promising technologies
for targeted genome editing in human cells have been introduced
recently (2–5), these are at present too cumbersome for routine,
genome-wide screening.
Nevertheless, systematic genetic screening directly in human
cells is highly desirable: for example, when working with in-
fectious human pathogens. Pathogens are often fast-evolving and
locked in a molecular “arms race” with their hosts; thus, their
interactions with cellular genes are often host-specific and must
be screened in the native host species. For systematically per-
turbing human genes, the most widely used method is RNA
interference (RNAi), which involves the use of commercial
libraries of synthetic small interfering RNA (siRNA) molecules
(6). A number of pioneering RNAi screens for host factors
required by human pathogens have already been conducted (7–
15), and many other human phenotypes have been screened as
well (16). Although these screens have revealed numerous
seminal insights into the molecular processes under study, they
have also highlighted recurring (and poorly understood) prob-
lems with respect to the reliability and specificity of RNAi
reagents used in high throughput. Among the initial hits from the
primary screens, a high prevalence of false positives is often
observed, forcing researchers to allocate significant resources to
validation and follow-up studies of each candidate gene. Fur-
thermore, the overlap between independently published screens
can be frustratingly low—as exemplified by the three initial
HIV screens that showed hardly any significant overlap in a
metaanalysis (17).
Apart from false positives generated by statistical noise or by
nonspecific toxicity of the RNAi reagents, the most problematic
sources of false positives are thought to be the sequence-
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dependent, so-called “off-target” effects (18). These are prob-
lematic because they can be highly reproducible and will thus not
be canceled out automatically over multiple replicates of the
same perturbation. Sequence-specific off-target effects may
originate from partial complementarity of the siRNA oligos to
unintended, noncognate cellular mRNA targets; such mRNAs
are bound by the siRNAs and subsequently perturbed in terms
of their stability and/or protein translation rate. At least some
of these off-target effects are presumably mediated by the
cellular microRNA-processing machinery, which mistakes
transfected siRNA oligos for endogenous microRNAs, load-
ing them onto the RNA-induced silencing complex and
scanning for mRNAs with suitable binding sites. Consistent
with this hypothesis, it has been observed that sequence-
dependent off-target effects of siRNAs are primarily controlled
and initiated by the “seed” region of their sequence (nucleo-
tide positions 2–8), similar to what is the case for microRNAs
(6, 19, 20). Matches to any given seed sequence typically occur
in several hundred different human transcripts, suggesting
that each off-target event can potentially perturb tens or
hundreds of genes simultaneously. A number of studies have
analyzed RNAi datasets for experimental evidence of seed-
mediated off-target effects (19–25), using both global gene-
expression readouts as well as defined, single-gene readouts
that have been the subject of screens. These studies reported that
“seed effects” can indeed be visible in the raw data and that they
can explain some of the unexpected or apparent false-positive
findings.
Here, we comprehensively quantify the prevalence of seed
effects in screens that address two important classes of pheno-
types: cellular infection by pathogens and cellular survival and
proliferation. Such complex phenotype/gene associations are the
central aim of genome-wide RNAi screening. We address this
issue in the context of three pathogen-infection screens, which
have been conducted in different laboratories, working with
three distinct pathogens. We analyze both the infection pheno-
types as well as the cellular proliferation phenotypes of these
screens, assuming them to be good representatives of complex
molecular processes involving many putative “hit” genes.
We find that seed-mediated phenotypes are dominating in all
three screens, to an extent that they threaten to camouflage on-
target phenotypes for all but the most clear-cut, strongest on-
target gene effects. In a systematic approach, we took advantage
of the strength of the observed seed effects to quantitatively
characterize the potential space of microRNA-like regulation of
pathogen entry/replication. We show that novel siRNA oligo
sequences can be designed that replicate the seed effect and that
strongly and specifically control the pathogens’ ability to infect
cells. In addition to consequences for screen design and analysis,
we are discussing possible implications for therapeutic applica-
tions and for the role of microRNAs in the evolution of re-
sistance toward pathogen infection.
Results
We analyzed raw data from genome-wide RNAi infection
screens for two invasive bacterial pathogens (Brucella abortus,
Salmonella typhimurium) and one virus (Uukuniemi virus, an
enveloped RNA virus of the Bunyaviridae family) (26). All three
screens were conducted using HeLa cells. Here, we are focusing
on the sequences of the individual siRNA oligos and how they
relate to the observed phenotypes (Fig. 1). For each of the three
different pathogens, the same commercially available, ge-
nome-wide, deconvoluted siRNA library was used. For the two
Fig. 1. Off-target effects in RNAi pathogen infection screens. (A) Experimental setup. HeLa cells were screened for host factors required for pathogen entry.
Microscopy images from two separate wells of a typical perturbation experiment are shown (DAPI-stained HeLa cell nuclei in blue; successful pathogen
infection in green from B. abortus expressing GFP). All three pathogens were screened using a genome-wide library (Qiagen), and Brucella and Salmonella
additionally with two kinome-wide libraries (Ambion, Dharmacon). (B) Intended on-target mechanism of siRNA action. Below, in the correlation plots, each
data point represents one gene, whereby the infection phenotypes (infection index) were averaged over all of the oligos designed for a given gene by a given
library vendor. (C) Unintended off-target mechanism of siRNA actions. Here, each data point represents one seed sequence, with phenotypes averaged over
all oligos that happen to contain that seed sequence in a given library. For all plots in B and C, pairs of oligos that happened to share the same seed sequence
and the same on-target gene (in any of the three libraries) were excluded. Note that intervendor comparisons are based on the subset of genes screened with
all three libraries (i.e., the kinome subset). Both correlations in C are highly significant (P ≤ 10−50).









bacterial pathogens, we complemented the genome-wide screens
with additional library screening focusing on the set of kinases
and kinase-related genes in the human genome, using siRNA
libraries from two other commercial vendors. All three libraries
typically consisted of four distinct siRNA oligos per human gene,
transfected and measured separately. The infection readouts
and other cellular phenotypes were assessed by automated
microscopy, followed by standardized image-processing proce-
dures (see Materials and Methods for a brief summary). The
analysis procedure included state-of-the-art normalization and
image-correction steps, and all phenotypes were z score-normalized
before further analysis. Apart from the infection phenotype, we
also systematically assessed the number of cells observed in each
well; this latter phenotype reflects the net sum of perturbation
effects on cell proliferation and survival and constitutes a second,
independent readout that should yield largely equivalent results
in all three screens.
First, we observed that the overall consistency of “on-target”
effects appeared to be surprisingly low: when comparing the
results of distinct oligos designed to target the exact same gene,
the phenotypes were virtually uncorrelated (Fig. 1 and Fig. S1).
This was the case both when comparing different oligos from the
same library and when comparing across the libraries from three
different commercial siRNA vendors. Even when averaging over
all oligos of a given gene in a given library, rank correlations
across libraries were often below 0.1 and never exceeded 0.2,
both for the infection phenotype as well as for the cell-number
phenotype (Fig. 1 and Fig. S1).
We next compared the oligos from different vendors again,
but this time not based on their designated on-targets (full 21-nt
complementarity), but instead based on their presumed off-tar-
gets (by grouping them according to the sequences of their
heptameric seed regions at nucleotide positions 2–8) (Fig. 1). If
phenotypes were attributable to the on-target (not the off-target)
mechanism, this second test should not yield any correlation—note
that all pairs of oligos that happened to share both the seed region
and the designated on-target were excluded.
Strikingly, however, we here observed much higher correla-
tions for all pairwise comparisons of library vendors (Fig. 1 and
Fig. S1). Correlations were highly significant, both for the case of
the infection phenotypes as well as for the cell-number pheno-
types. In 12 out of 12 comparisons, such “off-target correlations”
were significantly greater than the on-target correlations, usually
by a factor of five or more (Fig. S1). In our view, this suggests
that (i) the lack of correlation in the first test was not attributable
to improper screen execution, image processing, or normal-
izations, (ii) most of the siRNA oligos do result in nonrandom
phenotypes, and (iii) for all three commercial library vendors,
the average siRNA oligo is predominantly and reproducibly
acting via the off-target mechanism.
We next aggregated the entire genome-wide screening data
based on shared seed sequences (Fig. 2 and Dataset S1). Of the
theoretically possible “space” of 16,384 heptamer seeds, 64% are
represented in the genome-wide library, many by dozens of dif-
ferent siRNA oligos. Among the subset of seeds represented 10
times or more, we observe that roughly one third result in sta-
tistically significant infection phenotypes (by extension, this
fraction would likely apply also to nonobservable seeds that
happened to be insufficiently covered by the library). The sta-
tistical strength of this signal is high, with seed effects reaching
P values of 10−12, even after correcting for multiple testing
(Dataset S1). We observe that the seed signal is strictly position-
dependent with respect to the siRNA nucleotide sequence as
hardly any statistical signal remained when the seed was assumed
at the “wrong” position (Fig. 2). Moreover, our analysis also
confirms that there seem to be no off-target signals stemming
from the opposite (“passenger”) strand of the double-stranded
siRNA molecules (Fig. S2).
Fig. 2. Genome-wide screening data aggregated by shared seed sequences. (A) Visualization of the entire genome-wide data of the infection screen for
B. abortus, aggregated by the seed sequences found in the various siRNA oligos. Each data point represents one heptameric seed sequence, showing the
averaged phenotypes over all siRNA oligos that happen to share that seed. The color code indicates the statistical significance of the observed infection
phenotypes. For the negative control, data were plotted in exactly the same way, but the position of the seed in each siRNA oligo was incorrectly assumed to
be at positions 12–18. (B) Visualizations for all three pathogens screened here; blue dots mark the seeds that have been selected for experimental follow-up.
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To experimentally confirm our findings and to formally sep-
arate the off-target and on-target contributions to each pheno-
type, we selected a number of seed sequences for detailed follow-
up. For each of the three pathogens, four seeds were selected
that were predicted to reduce infection, plus one seed that would
enhance it (all marked in blue in Fig. 2B). Although the seeds
were selected to have strong phenotypes in the infection readout,
they were also chosen such that they had little effect on the cell
number (seed effects on infection and on host-cell viability were
often orthogonal). For each of the selected seeds, we first reor-
dered four standard inventory oligos from the genome-wide library;
in such inventory oligos, both the off-target and the intended on-
target component should still be present. Importantly, we also
designed novel oligos for each seed; for these oligos, the nucleotide
sequences outside the seed were arbitrarily set to a random string
of nucleotides (drawn from the background distribution of all oli-
gos in the genome-wide library). The design of these latter oligos
formally excludes any intended “on-target” component. For con-
trols, we reordered a population of arbitrary inventory oligos
chosen at random, as well as a set of inventory oligos with seeds
predicted to have no phenotype per se. Additionally, for some
seeds, we custom-designed oligos that were similar to the cor-
responding inventory oligos, except at one position within the
seed region where they differed by a single point mutation
(presumably, this should abolish any specific seed-mediated off-
target effects).
Upon rescreening all three pathogen-specific assays using the
new set of oligos, we indeed observed that the predicted phe-
notypes were clearly reproducible, both in the presence and in
the absence of any specific on-target component (Fig. 3 and
Fig. S3). The custom-designed oligos that featured arbitrary
sequences outside the seed were blocking infection just as ef-
fectively as the corresponding inventory oligos that still had
a designed on-target (Fig. 3; dark blue vs. light blue). By com-
parison, the overall effects of the oligos on the cell-number phe-
notypes were mild (Fig. S4) and often insignificant. We were able
to design oligos not only to block infection, but also to enhance it
if appropriate seeds were selected (orange colors in Fig. 3).
In all three screens, we observed that some of the seed
sequences that showed significant phenotypic effects coincided
with seed sequences known to be present in endogenous human
miRNAs. This raised the possibility of predicting the over-
expression phenotypes of such miRNAs—under the assumption
that the target-gene specificity of endogenous miRNAs is simi-
larly dictated to a large extent by the seed region. For the
B. abortus screen, we set out to test this prediction by selecting
eight distinct seed sequences shown to strongly block infection,
which were represented in the siRNA libraries at least 10 times,
and corresponded to exactly a single known human miRNA (we
did not consider matches to miRNA families having multiple
members that shared the same seed). Likewise, we chose eight
seeds that strongly enhanced infection and eight seeds that were
predicted to be neutral. For all 24 corresponding human miRNAs,
we ordered commercially available, double-stranded RNA mol-
ecules intended to mimic the native miRNA. Indeed, in all cases,
the predicted overexpression phenotype was confirmed experi-
mentally (Fig. 4 and Fig. S5).
Finally, we analyzed the specificity of the observed seed
effects. To test the sequence specificity, we introduced single-
point mutations into the seed regions; these mutations indeed
completely abolished the intended activity of the corresponding
siRNAs (Fig. 5A). To test the pathogen specificity, we searched
for seeds that would influence one pathogen, but not the other
two. This was based on the rationale that the distinct pathogens
should have different sequence- and pathway-specific require-
ments, and this should be reflected in the seed phenotypes. In-
deed, at a significance level of P ≤ 10−6, the majority of active
seeds (78%) affected only one pathogen. Nineteen percent of
active seeds affected two pathogens, and only 3% affected all
three pathogens significantly. Effectively, in our genome-wide
analysis, the observations for each seed sequence describe a
vector of six phenotypes: three distinct infection phenotypes
(“infection index”) and three independent replicates of the cell
viability/proliferation phenotype (“cell number”). Principal-
component analysis of this space reveals that the three cell-
number dimensions neatly fold into one component, capturing
about half of the variance (Fig. 5B). The remainder of the
phenotypes mostly discriminate between the pathogens—with
the virus being on one side and the two bacteria on the other
(often somewhat closer to each other than to the virus).
Overall, these results show that genome-wide datasets enable
the design of novel RNAs (which we term “seed drugs”) that
reproducibly block infection by one or more pathogens, without
Fig. 3. Experimental confirmation of predicted seed phenotypes. (A) De-
tailed phenotypes measured for B. abortus (six replicates per oligo). (B)
Summary of phenotypes measured for each of the three pathogens. The
siRNA oligos predicted to block infection are shown in blue (dark blue for
those that were designed not to have any on-targets), and oligos predicted
to enhance infection are shown in orange (again, dark orange if lacking on-
targets by design). The full sequences of all oligos in this experiment are
given in Fig. S3.









conferring pronounced toxic side effects on the host cell and
without targeting any one gene specifically by design.
Discussion
For complex genome-wide RNAi screens, our analysis suggests
that seed-mediated off-target effects can dominate the pheno-
typic readouts and may present a serious problem for properly
inferring the intended on-target effects. Considering that
genome-wide screens have the additional statistical problem of
massive multiple testing, it becomes evident that ad hoc gene
lists of “best hit” candidate genes can be severely contaminated
by seed-mediated off-target effects. Indeed, for the three screens
described here, we determined that, in a typical list of candidate
hit genes, much of the phenotypic effect comes from oligos with
“active” off-target seeds—there are roughly twofold more such
oligos among top-scoring genes than expected by chance (i.e.,
comparing with a random selection of genes of the same size
from the same screen) (Fig. S6). Therefore, a sizable fraction of
candidate-gene hits are probably false positives (with respect to
the intended on-target effect). Nevertheless, for about half of the
phenotypes/screens, significant overlaps between the libraries are
detectable (Fig. S1) (see Fig. S9), and these screens will typically
lead to confident, true positive hits upon rescreening and further
validation.
We find that seed effects are also present in published large-
scale RNAi datasets that have been corrected for indirect effects
occurring through changes in a single cell’s microenvironment
(27, 28) (“population context”) (Fig. S7). This observation
indicates that seed effects likely act directly on the molecular
machinery underlying pathogen infection inside single cells, and
not via population context only. In our hands, the phenotypic
variance introduced by the seed effect is clearly larger than the
variance observed across multiple biological or technical repli-
cates of the same perturbation. Thus, it seems advisable to
repeat RNAi measurements using as many different oligo se-
quences as possible, aiming to average out seed effects, rather
than conducting multiple biological replicates of the very same
oligos. Furthermore, to systematically learn and correct for seed
effects from the data itself is difficult, as most seeds are not
represented well enough in genome-wide libraries to learn their
phenotypic mean and variance reliably. A possible strategy for
the future would be to redesign genome-wide libraries to use
a deliberately restricted set of seeds (which should still be on the
order of hundreds of seeds—but these seeds would be designed
to be represented frequently enough in the library to learn and
correct for their effects). To pool distinct oligos intended for the
same gene may also be a strategy although we clearly observed
significant seed effects in pooled libraries as well (Fig. S8).
In principle, it should be possible to use the known sequences
of human mRNAs (particularly their 3′ UTR sections) to predict
where the various siRNA oligos might bind to mRNAs and how,
cumulatively, this might bring about the observed phenotypes.
Two software pipelines dedicated to this task have been pub-
lished already, GESS (“Genome-Wide Enrichment of Seed Se-
quence Matches”) (25) and Haystack (21). However, at least for
the phenotypes screened here, both approaches failed to enrich
Fig. 4. Human miRNA overexpression phenotypes. (A) Based on the B. abortus genome-wide siRNA screen, specific seeds were selected that happened to
occur also in known, endogenous human miRNAs. Eight of these seeds were predicted to reduce infection, eight were predicted to enhance infection, and
eight were predicted to be neutral. To be selected, seeds had to be represented at least 10 times in the siRNA library and had to correspond to a single known
human miRNA only. The figure shows the infection outcomes of transfecting these known miRNAs (as molecular mimics), compared with their predicted
phenotypes as inferred from the seed analysis. (B) Tabulated details of the eight human miRNAs that were predicted, and confirmed, to block infection.
Fig. 5. Specificity of seed effects. (A) Effects of single-point mutations located in the seed regions. For each of the three pathogens, one seed was chosen that
was predicted to block infection (data shown in blue). Shown in gray are data for the corresponding seeds that have been mutated at one position. For both
the standard inventory oligos as well as for oligos designed to have no full-length on-target sequence match, the infection phenotype is abolished upon
mutating the seed sequence. (B) Principal component analysis (PCA) over the entire space of seed phenotypes observed for the three pathogens. (Left)
Projection of the first two components of the PCA (each data point represents one seed; only seeds observed in at least 10 independent siRNA oligos are
included). The seed effects on the cell numbers are virtually identical for all three pathogens, and align well with the first PCA dimension, which explains
about 50% of the variance. (Right) Dimensions #2 and #3 separate the three pathogens (seeds are color-coded according to the pathogen for which they
show the most significant infection-index phenotype).
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for “causal,” on-target genes, as judged by their inability to im-
prove interlibrary correlations (Fig. S9). In a similar vein, for
those active seeds that happen to coincide with known, endog-
enous human miRNAs, it might be possible to explain some of
their off-target effects by searching for predicted targets of those
known miRNAs among the top hit lists of the primary screens.
However, upon testing three different miRNA target-prediction
algorithms (29–31), we did not observe any significant overlap
between primary hits and predicted miRNA targets (Fig. S10).
On the positive side, it has become evident that each genome-
wide screen represents a powerful interrogation of the sequence
space of natural and synthetic miRNA seeds. Natural miRNAs
often act as endogenous regulators of entire pathways and pro-
cesses (as opposed to regulating individual genes only). If we
assume that synthetic miRNA seeds can mimic their natural
counterparts mechanistically (e.g., with respect to regulating
susceptibility to infectious agents), then genome-wide siRNA
screens provide a potent tool to assess whether and how host
organisms might evolve pathogen resistance by creating new
miRNAs. In many cases, it might take only a very small number
of mutations to change an existing miRNA into one that is ef-
fective against a new pathogen. Experimentally, any strategy for
screening the space of miRNA seeds might quickly yield potent
therapeutics or laboratory reagents for many processes of in-
terest. Perhaps the most important conclusion of our analysis,
however, is that raw “oligo-by-oligo” phenotypic data of genome-
wide RNAi screens clearly merit a second look and can yield
interesting new insights—provided they are made available to
researchers worldwide (32).
Materials and Methods
For the genome-wide infections screens, HeLa cells were grown in 384-well
microtiter plates and reverse-transfected with siRNAs 72 h before infections.
Pathogens were added, and their cell entry was assessed after a specified
incubation time, using pathogen-specific single-cell readouts in high-
throughput automated microscopy imaging of each well. Incubation times
were as follows: 4 h for S. typhimurium, 44 h for B. abortus, and 20 h for
Uukuniemi Virus. The detailed experimental methods for each pathogen
assay will be published elsewhere. For the data analysis, microscopy images
were scaled, corrected for shading, segmented into objects using CellProfiler,
and quantitative features were extracted for each cell (up to 200 features
per cell). Nuclei and cell bodies were recognized based on DAPI and Actin
stainings, respectively. Extracted quantitative features included intensity,
texture and shape. Pathogen-specific procedures were then used to dis-
criminate infected from uninfected cells, using Decision Trees with user-
provided thresholds on selected single-cell features such as GFP intensity.
The phenotypes in each well were normalized first by plate-wise Z-scoring,
then by experiment-wide Z-scoring, followed by population regression (Lowess),
to control for systematic dependencies between cell-number, -density, and in-
fection rate. Well-by-well resolved, library-wide phenotypes for the three
pathogens and the three libraries are available in Datasets S2–S4. The
nucleotide sequences of all library siRNA oligos were kindly provided by
the commercial vendors. The statistical significance of seed-mediated off-
target effects was assessed by aggregating all oligos containing a given seed
and comparing the distribution of their phenotypes with the background
distribution of phenotypes from the entire screen, using two-sided Kolmogorov–
Smirnov tests. Correction for multiple testing was according to Benjamini
and Hochberg (33). Human miRNA overexpression experiments were con-
ducted using Dharmacon miRIDIAN microRNA mimics, in the same cell line as
the primary screens.
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